These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 2995431
1. Direct action of opiates on bromocriptine-inhibited prolactin release by human prolactinoma cells in primary culture. Castanas E, Jaquet P, Gunz G, Cantau P, Giraud P. J Clin Endocrinol Metab; 1985 Nov; 61(5):963-8. PubMed ID: 2995431 [Abstract] [Full Text] [Related]
2. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions. Jaquet P, Gunz G, Grisoli F. Horm Res; 1985 Nov; 22(3):153-63. PubMed ID: 3932176 [Abstract] [Full Text] [Related]
3. Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells. Lamberts SW, Verleun T, Hofland L, Oosterom R. J Clin Endocrinol Metab; 1986 Dec; 63(6):1342-7. PubMed ID: 3782422 [Abstract] [Full Text] [Related]
5. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M, Yamaji T. J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [Abstract] [Full Text] [Related]
6. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe. Stojilković SS, Dufau ML, Catt KJ. Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471 [Abstract] [Full Text] [Related]
7. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N. Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236 [Abstract] [Full Text] [Related]
14. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW. J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915 [Abstract] [Full Text] [Related]
16. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma. Castanas E, Giraud P, Audigier Y, Drissi R, Boudouresque F, Conte-Devolx B, Oliver C. Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951 [Abstract] [Full Text] [Related]
17. Abnormal dopamine sensitivity in some human prolactinomas. Pellegrini I, Costa R, Grisoli F, Jaquet P. Horm Res; 1989 Jan; 31(1-2):19-23. PubMed ID: 2722137 [Abstract] [Full Text] [Related]
18. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin. Faure N, Cronin MJ, Martial JA, Weiner RI. Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521 [Abstract] [Full Text] [Related]